Cel Cortechs is addressing an exponentially growing brain-based health challenge impacting over 2 billion people and 1 in 9 children worldwide: the inability to reach the basic cognitive skill levels needed to maintain the attention needed for school, work, home and life. Cortechs create data-driven, therapeutic games that improve attention levels in children. ADHD is expensive, it causes suffering and it impairs social and lifelong productivity for the child and their family. Each task a child partakes in needs their full attention to be performed successfully. While this statement may seem obvious, the reality is that current EU-wide approaches to treat these symptoms come at extortionate costs (trillions pa) to the European health and welfare systems with medication alone not tackling the core, cognitive skills affected in ADHD. Our intervention provides games which can be played using your brainwaves on smart devices. Progress data can be remotely assessed by specialist clinicians to prescribe and amend individual therapies on secure web dashboards. Cortechs neurofeedback platform and gaming delivery system is a highly innovative, consumer facing solution in the cognitive healthcare market for ADHD. Therapeutics in cognitive impairments (CI) is a high-volume market valued at €80 billion and will grow to €393 billion market by 2022. Our Cortechs enterprise platform (called Cerebrill) applies key evidence-based ADHD treatments in an end-to-end digital solution with access to easy-to-use, engaging smart brainwave games to improve their behaviours. The solution is device agnostic, cheaper and accessible anywhere with prescriptives remotely and securely controlled and moderated by clinicians. This proposal would enable Cerebrill to be speedily commercialised to enterprise alongside a regulatory clinical validation process so Cortechs can offer Cerebrill as a therapy for improving attention symptoms in the ADHD healthcare space within 24 months. Dziedzina nauki social scienceseducational sciencesdidacticsmedical and health sciencesbasic medicineneurologyepilepsymedical and health scienceshealth sciencespublic healthmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugssocial scienceseconomics and businesseconomicshealth economics Słowa kluczowe Assistive technology brain plasticity big data ADHD attention healthcare digital therapeutic cognitive impairment behavioural changes children life skill acquisition games machine learning Program(-y) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Temat(-y) EIC-SMEInst-2018-2020 - SME instrument Zaproszenie do składania wniosków H2020-EIC-SMEInst-2018-2020 Zobacz inne projekty w ramach tego zaproszenia Szczegółowe działanie H2020-SMEInst-2018-2020-2 System finansowania SME-2 - SME instrument phase 2 Koordynator CORTECHSCONNECT LIMITED Wkład UE netto € 1 268 750,00 Adres 125 BELFRY HALL CITYWEST D24X D45 Dublin Irlandia Zobacz na mapie MŚP Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant. Tak Region Ireland Eastern and Midland Dublin Rodzaj działalności Private for-profit entities (excluding Higher or Secondary Education Establishments) Linki Kontakt z organizacją Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Koszt całkowity € 1 812 500,00